Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma
- 10.11.2017
- Original Article
Erschienen in:
- Verfasst von
- Max Rohde
- Anne L. Nielsen
- Jørgen Johansen
- Jens A. Sørensen
- Anabel Diaz
- Jon T. Asmussen
- Oke Gerke
- Anders Thomassen
- Niels Gyldenkerne
- Helle Døssing
- Kristine Bjørndal
- Poul Flemming Høilund-Carlsen
- Christian Godballe
Abstract
Purpose
In patients with newly diagnosed head and neck squamous cell carcinoma (HNSCC), we wanted to examine the differences in overall treatment decisions, i.e. curative versus palliative treatment intent, reached by a multidisciplinary team conference (MDTC) based on 18F–fluoro-deoxy-glucose-positron emission tomography/computed tomography (PET/CT) or chest X-ray + MRI of the head and neck (CXR/MRI).
Patients and methods
This was a prospective blinded cohort study based on paired data. Consecutive patients with histologically verified primary HNSCC were invited to participate. All included patients underwent CXR/MRI and PET/CT before diagnostic biopsy. An ordinary MDTC using all available imaging was conducted as per standard practice. After at least 3 months (to eliminate recall bias in the team), the first project MDTC was conducted, based on either CXR/MRI or PET/CT, and the tumor board drew conclusions regarding treatment. After an additional 3 months, a second project MDTC was conducted using the complementary imaging modality.
Results
A total of 307 patients were included. Based on CXR/MRI, 303 patients (99%) were recommended for curative treatment and only four patients (1%) for palliative treatment. Based on PET/CT, the MDTC concluded that 278 (91%) patients were suitable for curative treatment and 29 (9%) patients for palliative treatment. The absolute difference of 8% was statistically significant (95% CI: 4.8%–11.5%, p < 0.001).
Conclusions
A PET/CT-based imaging strategy significantly changed the decisions regarding treatment intent made by a MDTC for patients diagnosed with HNSCC, when compared with the standard imaging strategy of CXR/MRI.
Anzeige
- Titel
- Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma
- Verfasst von
-
Max Rohde
Anne L. Nielsen
Jørgen Johansen
Jens A. Sørensen
Anabel Diaz
Jon T. Asmussen
Oke Gerke
Anders Thomassen
Niels Gyldenkerne
Helle Døssing
Kristine Bjørndal
Poul Flemming Høilund-Carlsen
Christian Godballe
- Publikationsdatum
- 10.11.2017
- Verlag
- Springer Berlin Heidelberg
- Erschienen in
-
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 4/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089 - DOI
- https://doi.org/10.1007/s00259-017-3873-3
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.